Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Oxurion NV (GB:0G99)
LSE:0G99
Holding GB:0G99?
Track your performance easily
0G99 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.27 - €2.00
Previous Close€0.27
Volume0.00
Average Volume (3M)3.00
Market Cap
€725.29K
Enterprise Value€5.15M
Total Cash (Recent Filing)€3.59M
Total Debt (Recent Filing)€8.02M
Price to Earnings (P/E)―
Beta-1.07
Next Earnings
Mar 13, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-26.40
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. Volume3
Standard Deviation1208.34
R-Squared0.00603
Alpha229.13
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)0.67
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Oxurion NV News
PremiumCompany Announcements
Oxurion Sees Significant Shareholder Activity by Atlas
PremiumCompany Announcements
Oxurion Expands Capital for Eye Care Innovations
PremiumCompany Announcements
Oxurion Sees Stake Reduction by Atlas Special Opportunities
PremiumCompany Announcements
Oxurion Awaits French Approval for Acquisition
PremiumCompany Announcements
Oxurion NV Ends Reorganization, Reduces Debt
PremiumCompany Announcements
Atlas Special Opportunities Acquires 20% Stake in Oxurion NV
PremiumCompany Announcements
Oxurion NV Expands Capital, Eyes Vision Therapy Market
PremiumCompany Announcements
Oxurion NV Experiences Significant Shareholding Changes0G99 FAQ
What was Oxurion NV’s price range in the past 12 months?
Oxurion NV lowest share price was €0.27 and its highest was €2.00 in the past 12 months.
What is Oxurion NV’s market cap?
Currently, no data Available
When is Oxurion NV’s upcoming earnings report date?
Oxurion NV’s upcoming earnings report date is Mar 13, 2025 which is in 91 days.
How were Oxurion NV’s earnings last quarter?
Oxurion NV released its earnings results on Sep 30, 2024. The company reported -€2.5 earnings per share for the quarter, missing the consensus estimate of N/A by -€2.5.
Is Oxurion NV overvalued?
According to Wall Street analysts Oxurion NV’s price is currently Overvalued.
Does Oxurion NV pay dividends?
Oxurion NV does not currently pay dividends.
What is Oxurion NV’s EPS estimate?
Oxurion NV’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Oxurion NV have?
Oxurion NV has 2,567,406 shares outstanding.
What happened to Oxurion NV’s price movement after its last earnings report?
Oxurion NV reported an EPS of -€2.5 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Oxurion NV?
Currently, no hedge funds are holding shares in GB:0G99
---
Oxurion NV Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-61.49%
Trailing 12-Months
Company Description
Oxurion NV
Oxurion NV is a biopharmaceutical company. The company is focused on developing treatments to preserve vision for patients with diseases affecting the back of the eye. It has developed a diverse portfolio of disease-modifying drug candidates, including treatments for diabetic eye disease, a leading cause of blindness in people of working age worldwide. It owns the global rights to Jetrea (ocriplasmin), the pharmacological vitreolysis drug approved for the treatment of symptomatic vitreomacular adhesion (in the U.S.) and vitreomacular traction (outside the U.S.).
---
Technical Analysis
---